Morgan Stanley’s Nexalin Technology NXL Stock Holding History

Morgan Stanley’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-500	Closed	-$494	–	8303
2025 Q2	$494	Hold	500	–	–	﹤0.01%	7451
2025 Q1	$975	Buy	+500	New	+$1.37K	﹤0.01%	7283
2024 Q3	–	Sell	-59,805	Closed	-$101K	–	8002
2024 Q2	$101K	Buy	+59,805	New	+$87.9K	﹤0.01%	5961
2023 Q3	–	Sell	-1,259	Closed	-$1.13K	–	7682
2023 Q2	$1.13K	Hold	1,259	–	–	﹤0.01%	7279
2023 Q1	$1.01K	Sell	1,259 -785	-38%	-$778	﹤0.01%	7353
2022 Q4	$1.53K	Buy	+2,044	New	+$3.13K	﹤0.01%	7412

Other funds holding NXL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Morgan Stanley's NXL Position: Q3 2025 in Review

Morgan Stanley sold out of Nexalin Technology (NXL) in Q3 2025, closing a stake of 500 shares — an estimated $494 sold.

Morgan Stanley first reported a position in NXL in Q4 2022 and held it in 6 quarters. The position peaked at $101K in Q2 2024. 20 funds tracked by Wall St. Rank hold NXL as of Q3 2025.

Morgan Stanley reported no remaining Nexalin Technology position as of Q3 2025 after selling out during the quarter.
Morgan Stanley sold 500 Nexalin Technology shares in Q3 2025, an estimated $494.
Morgan Stanley first reported a position in Nexalin Technology in Q4 2022 and held it in 6 quarters.
Morgan Stanley's Nexalin Technology position peaked at $101K in Q2 2024.
20 funds tracked by Wall St. Rank held Nexalin Technology as of Q3 2025.

Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.